RecruitingNCT06341166
Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse
Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse: the SCIMITAR Trial
Sponsor
Centro Cardiologico Monzino
Enrollment
300 participants
Start Date
Jun 19, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This is a multicenter, observational prospective and retrospective study which aims are: 1) to compute a scoring model potentially predictive for the diagnosis of fibrosis by CMR in patients with MVP; 2) to identify specific features that may predispose to ≥ mild VAs or SCD in patients with MVP.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- age ≥ 18 years
- Echocardiographic diagnosis of mitral valve prolaspe, defined as a systolic displacement of one or both mitral leaflets ≥ 2 mm above the plane of the mitral valve annulus in long-axis views
Exclusion Criteria4
- age< 18 years
- coexistence of other cardiomyopathies or other ≥ moderate valve diseases
- scarce acoustic transthoracic echocardiographic window
- usual contraindications for cardiac magnetic resonance
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06341166
Related Trials
Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm Monitoring
NCT063789961 location
AI-Based Shape and Function Analysis of Mitral Valve Prolapse Using 3D Ultrasound
NCT073848711 location
Ventricular Arrhythmias in Patients Undergoing Mitral Valve Surgery
NCT062554571 location
PRIMARY Ancillary Substudy
NCT0710373325 locations
Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse
NCT056317301 location